Monday, February 29, 2016

Reflection on the editorial process


The engine of high quality peer review fuels authors’ careers and prestige, successful applications for future research support, and ultimately moves forward the field. The associate editor (AED) of a scientific journal is therefore entrusted with the important responsibility of ensuring high quality peer review of manuscripts submitted to the respective journal. There is an expectation that the AEDs will carefully choose the reviewers that will provide accurate technical appraisal of the work. This is especially important when faced with increasing multidisciplinary scientific reports. The AEDs should themselves appraise the manuscript while balancing reviewers’ comments and communicate clearly and timely what additional work is reasonably necessary to elevate the report to be accepted for publication, or why the work may not be suited for the respective journal. In this age of juggling multiple responsibilities during an ever-diminishing available time, there is a risk of erosion of the quality of work that the AED is expected to do. All too often, as authors or reviewers of manuscripts, we note that AED decisions are the rubberstamp of increasingly frustrated or hurried reviewers, or they follow the path of least resistance to a quick and not necessarily fair decision. Such habits erode the trust in the effectiveness of the current peer review processes and threaten the engine of the scientific progress. Our editorial team at AJP-Lung is striving to abide by the important principles of high quality peer review. We believe that this purposeful work is linked to the increase in the number of manuscripts we are receiving for peer review and will translate in the progress of our field.

Irina Petrache, MD
Associate Editor, AJP Lung

Wednesday, February 10, 2016

The APS AuthorChoice Program

The APS AuthorChoice program was developed to allow researcher authors the ability to provide immediate, open and free access to their work without the standard 12-month embargo that applies to subscription access.

The fee for research articles is $2,000 (plus color fees, if applicable) and for review articles, $3,000. Articles published with the AuthorChoice option for open and free access are covered by the Creative Commons Attributions license (CC BY) https://creativecommons.org/licenses/), under which all are eligible for reuse and distribution under the condition that the original work published by APS must be cited.

Additional information can be found here:   FAQ

Monday, February 8, 2016

APSselect February 2016

AJP-Lung would like to congratulation Dr. Olave and colleagues on being selected as a APSselect article for February 2016.  You can read this outstanding article by clicking here:  Regulation of Alveolar Septation by MicroRNA-489.

Friday, February 5, 2016

Thursday, February 4, 2016

Respiration Section Banquet At EB2016 - ***DEADLINE EXTENDED 2/15/16***

Dear Respiration Section Members,

The website for purchasing tickets for the Respiration Section Banquet  at Experimental Biology in San Diego is now live (see below)! The dinner will take place on  Monday,  April 4 starting at 6:30 pm at Maritime Museum. Tickets to the Respiration Section Banquet  is quite popular and sells out very quickly.

***DEADLINE HAS BEEN EXTENDED TO 2/15/16*** Don’t hesitate! Buy your tickets today!

Thanks to those  who have already purchased tickets.  For USA Residents, your tickets will be mailed out around the first week of March.  For International Ticket Holders, you will pick up your tickets onsite.  An email will be sent to you around the first week of March with details on where to pick up your tickets at EB16.

Please click on the link below to purchase your tickets today.

Respiration Section Banquet



Best regards,

Ann Marie Bocus
Sections Coordinator

Tuesday, January 19, 2016

AJP-Lung Submissions Rise

We would like to thank all of our contributors in 2015. Our submissions  have increased over 20% from 2014.   We were, in fact, one of the few APS journals to show growth.

Thank you for your submissions.





The journal title is     AJP-Lung    
Published research pages to date are   2361    
Published editorial pages to date are   407    
Projected total pages for 2015 are   2768    
The page cap is      2400    
Pages (over)/under cap are   (368)    






  # Research Manuscripts recv thru 4Q 2015 # Research Manuscripts recv thru 4Q 2014 YTD Change No.  YTD Change %  
AJP-Cell 319 374 -55 -15%  
AJP-Endo 525 613 -88 -14%  
AJP-GI&L 419 436 -17 -4%  
AJP-Heart 852 833 19 2%  
AJP-Regu 496 480 16 3%  
AJP-Renal 462 518 -56 -11%  
AJP-Lung 426 356 70 20%  
Total AJP 3,499 3,610 -111 -3%  

Sunday, January 17, 2016

New insights into the complex role of estrogen in influenza

In the recent 2009 H1N1 pandemic young adult women experienced greater mortality than age-matched men. Murine models show worse outcomes in adult females compared to males. So estrogen is bad for influenza, right? Not so fast! In a recent AJP Lung paper that has garnered media attention (http://www.sciencedaily.com/releases/2016/01/160112093424.htm),  Dr. Sabra Klein and colleagues report that estrogen or compounds with estrogen-like activity actually reduce influenza virus replication in primary human nasal epithelial cells—but only in those from female, not male, donors. The effect is mediated through the 2nd genomic estrogen receptor, ER-beta, since neither of the other two ER receptors (ER-alpha or GPR30) were expressed in the nasal epithelial cells, and an ER antagonist could block estrogen’s effects. Transcriptome profiling showed marked down-regulation of zinc-finger proteins, an intriguing clue to possible molecular mechanisms for both the anti-proliferative effect and the sex selectivity . This work expands on past studies from the Klein lab showing that pharmacologic or high levels of estrogen can have beneficial effects on influenza outcome in mouse models, while recognizing that normal low levels may have paradoxical pro-inflammatory or harmful effects. The biphasic nature of hormone effects is well known, and these data are a fascinating addition to the important role of sex hormones in modulating outcomes in infectious disease.

To find out more about this interesting study, please check out the full text of this article. It is available for free on the AJP-Lung website, even for those with no subscription to APS journals:
http://ajplung.physiology.org/content/early/2015/12/17/ajplung.00398.2015

Dr. Lester Kobzik